>> Sponsored Symposia MSD

Print PDF
Tuesday, July 6, 2010
12:30-14:00

Lunch Symposium organized by Merck Sharp & Dohme
OUTSTANDING SCIENTIFIC & PUBLIC HEALTH ISSUES IN THE HPV FIELD

Welcome and introduction

Dr. Marc Steben, Department of Medicine, Institut national de santé publique du Québec, QC, Canada

Gender neutral vaccination –
The path forward

Dr. Anna Giuliano, H. Lee Moffitt Cancer Centre & Research Institute, University of South Florida, Tampa, FL, USA

HPV vaccination of sexually active women: What matters to the clinician

Dr. Elmar Joura, University Hospital Vienna, Vienna, Austria
The real life impact of GARDASILTM:
An update of the Australian experience		 Dr. Andrew Grulich, University of New South Wales, NSW, Australia

Evaluating the impact of female HPV vaccination in low-coverage settings:
The influence of male partners

Dr. Ann Burchell, Ontario HIV Treatment Network, Toronto, ON, Canada

Panel discussion and closing remarks

Dr. Eduardo Franco, Division of Cancer Epidemiology, McGill University, Montreal, QC, Canada

 

Learning Objectives:
  • Educate on the Importance of High Immunization Rates to get the maximum Public Health Benefit
  • Educate Audience on Upcoming and important Public Health Policy Decisions
  • Educate on Importance of New Indication for GARDASIL